Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ladenburg Thalmann Downgrades Artivion to Neutral, Raises Price Target to $38.8

Author: Benzinga Newsdesk | August 13, 2025 11:16am
Ladenburg Thalmann analyst Jeff Cohen downgrades Artivion (NYSE:AORT) from Buy to Neutral and raises the price target from $32 to $38.8.

Posted In: AORT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist